Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032
Overview
The Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is expected to reach a 358.94 USD Million by 2032 and is projected to grow at a CAGR of 9.93% from 2025 to 2032.
Revenue, 2024 (USD Million)
168.87
Forecast, 2032 (USD Million)
358.94
CAGR, 2024 - 2032
9.93%
Report Coverage
Asia-Pacific
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market 2018-2032 USD Million
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 168.87 USD Million
- Projected Market Size (2032): 358.94 USD Million
- CAGR (2025-2032): 9.93%
Key Findings of Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market
- The Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at 168.87 USD Million in 2024.
- The Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is likely to grow at a CAGR of 9.93% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Beta Emitters in Isotope Segment accounted for the largest share of the market with a revenue of 145.67 USD Million
- The fastest growing segment Small Molecule Ligands in Vector Type Segment grew Fastest with a CAGR of 10.43% during the forecast period from 2024 to 2032.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Scope
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Segmentation & Scope
Therapeutic Application
- Others
- Oncology
Vector Type
- Others
- Monoclonal Antibodies
- Peptides
- Small Molecule Ligands
End User
- Research Institutes
- Radiopharmacies
- Hospitals
Isotope
- Alpha Emitters
- Beta Emitters
Sources
- Others
- Generator-Produced Isotopes
- Reactor-Produced Isotopes
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 168.87 USD Million |
| Market Value in 2032 | 358.94 USD Million |
| CAGR (2025-2032) | 9.93% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Therapeutic Application,Vector Type,End User,Isotope,Sources |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 168.87 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 32.19 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Therapeutic Application
- Oncology is the largest segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 131.21 USD Million in the year 2024.
- Oncology is the Fastest growing segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.24 % in forecast period 2025-2032.
-
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Vector Type
- Small Molecule Ligands is the largest segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 90.00 USD Million in the year 2024.
- Small Molecule Ligands is the Fastest growing segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.43 % in forecast period 2025-2032.
-
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 98.46 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.04 % in forecast period 2025-2032.
-
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Isotope
- Beta Emitters is the largest segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 145.67 USD Million in the year 2024.
- Beta Emitters is the Fastest growing segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.00 % in forecast period 2025-2032.
-
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Sources
- Reactor-Produced Isotopes is the largest segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 106.73 USD Million in the year 2024.
- Reactor-Produced Isotopes is the Fastest growing segment in Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 10.04 % in forecast period 2025-2032.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Share Analysis
| Company Name |
|
||
| Novartis AG | |||
| Eckert & Ziegler | |||
| ITM Isotope Technologies Munich SE | |||
| SHINE Technologies, LLC | |||
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is segmented based on Segmentation Therapeutic Application,Vector Type,End User,Isotope,Sources.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at USD 168.87(Revenue in USD Million) in 2024.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is projected to grow at a CAGR of 9.93% during the forecast period of 2024 to 2032.
The Beta Emitters segment is expected to dominate the Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market, holding a largest market share of 145.67 USD Million in 2024
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Scope
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Segmentation & Scope
Therapeutic Application
- Others
- Oncology
Vector Type
- Others
- Monoclonal Antibodies
- Peptides
- Small Molecule Ligands
End User
- Research Institutes
- Radiopharmacies
- Hospitals
Isotope
- Alpha Emitters
- Beta Emitters
Sources
- Others
- Generator-Produced Isotopes
- Reactor-Produced Isotopes
Frequently Asked Questions
The Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is segmented based on Segmentation Therapeutic Application,Vector Type,End User,Isotope,Sources.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at USD 168.87(Revenue in USD Million) in 2024.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is projected to grow at a CAGR of 9.93% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market for final year is USD 358.94 (USD Million).
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is segmented based on Segmentation Therapeutic Application,Vector Type,End User,Isotope,Sources.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at USD 168.87(Revenue in USD Million) in 2024.
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market is projected to grow at a CAGR of 9.93% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market for final year is USD 358.94 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 7500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.